Table 1 GI adverse events
From: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
GI adverse events | Grade | Patients | Total number events |
|---|---|---|---|
Anorexia | 1 | 9 | 13 |
2 | 3 | 3 | |
Weight Loss | 1 | 6 | 7 |
Emesis | 1 | 5 | 8 |
Nausea | 1 | 2 | 2 |
Lethargy | 1 | 4 | 5 |
Diarrhea | 1 | 6 | 8 |
2 | 3 | 4 | |
Increased BUN, Normal Creatinine | 1 | 2 | 3 |
2 | 3 | 3 |